Brokerages Set Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Target Price at $10.15

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) has been given a consensus recommendation of “Reduce” by the eleven research firms that are covering the firm, Marketbeat reports. Four investment analysts have rated the stock with a sell recommendation, six have issued a hold recommendation and one has given a buy recommendation to the company. The average 12 month target price among brokers that have issued ratings on the stock in the last year is $10.15.

Several equities research analysts have commented on WBA shares. UBS Group reissued a “neutral” rating on shares of Walgreens Boots Alliance in a report on Thursday, June 26th. Morgan Stanley reiterated an “underweight” rating on shares of Walgreens Boots Alliance in a research report on Thursday, June 26th. Finally, Wall Street Zen initiated coverage on Walgreens Boots Alliance in a research report on Wednesday, May 21st. They set a “hold” rating for the company.

Hedge Funds Weigh In On Walgreens Boots Alliance

Institutional investors have recently added to or reduced their stakes in the company. Osaic Holdings Inc. lifted its stake in shares of Walgreens Boots Alliance by 15.1% in the 2nd quarter. Osaic Holdings Inc. now owns 285,535 shares of the pharmacy operator’s stock valued at $3,261,000 after purchasing an additional 37,396 shares during the last quarter. Stance Capital LLC purchased a new position in shares of Walgreens Boots Alliance in the 2nd quarter valued at $3,799,000. Marex Group plc purchased a new position in shares of Walgreens Boots Alliance in the 2nd quarter valued at $305,000. Hudson Bay Capital Management LP grew its stake in Walgreens Boots Alliance by 31.7% during the 2nd quarter. Hudson Bay Capital Management LP now owns 790,198 shares of the pharmacy operator’s stock worth $9,071,000 after buying an additional 190,198 shares during the last quarter. Finally, Caxton Associates LLP grew its stake in Walgreens Boots Alliance by 397.0% during the 2nd quarter. Caxton Associates LLP now owns 1,143,287 shares of the pharmacy operator’s stock worth $13,125,000 after buying an additional 913,263 shares during the last quarter. Hedge funds and other institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Price Performance

Shares of Walgreens Boots Alliance stock opened at $11.98 on Wednesday. The company has a debt-to-equity ratio of 0.96, a current ratio of 0.60 and a quick ratio of 0.32. The business’s 50 day simple moving average is $11.77 and its two-hundred day simple moving average is $11.34. The stock has a market capitalization of $10.37 billion, a P/E ratio of -1.64, a price-to-earnings-growth ratio of 1.42 and a beta of 0.80. Walgreens Boots Alliance has a one year low of $8.08 and a one year high of $13.25.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Thursday, June 26th. The pharmacy operator reported $0.38 earnings per share for the quarter, topping analysts’ consensus estimates of $0.34 by $0.04. The firm had revenue of $38.99 billion for the quarter, compared to analyst estimates of $36.72 billion. Walgreens Boots Alliance had a positive return on equity of 17.66% and a negative net margin of 4.07%.The business’s quarterly revenue was up 7.2% compared to the same quarter last year. During the same period last year, the company earned $0.63 EPS. Analysts forecast that Walgreens Boots Alliance will post 1.6 EPS for the current year.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.